GMP manufacturing at millilitre scale
mRNA, synthetic and plasmid DNA, and gene and personalized therapies are increasingly produced in GMP runs at flow rates of mL/min rather than L/min.
At this scale, any oversizing, such as using conventional 1/8-inch equipment where 1/16-inch would be more appropriate, can significantly compromise process performance. It introduces control instability, response delays, excessive dead volumes, cumulative product losses at each step, and unwanted dilution, ultimately reducing overall process efficiency and product recovery.

